Key result
SK-121 digital health intervention fails to reduce cardiovascular risk scores post-PCI versus standard of care.
Why the study?
To evaluate a multimodal digital health intervention (SK-121) as an adjunct to standard of care to reduce the risk of recurrent cardiovascular events in patients following PCI.
Does a multimodal digital health intervention added to standard of care reduce the SMART2 risk score in patients following percutaneous coronary intervention?
RCT (n=200)
Open-label
1:1
No
Does a multimodal digital health intervention added to standard of care reduce the SMART2 risk score in patients following percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
A 48-week digital health intervention after PCI did not significantly reduce the SMART2 risk score at 6 months compared to standard of care, though it improved disease knowledge and short-term medication adherence.
Aims To evaluate a multimodal digital health intervention (SK-121) as an adjunct to standard of care (SoC) to reduce the risk of recurrent cardiovascular events in patients following percutaneous coronary intervention (PCI). Methods and results In this single-centre, randomised controlled trial of 200 patients (mean age 64.4 years; 79.5% male) who underwent PCI, patients were randomised 1:1 to receive SoC alone or SoC plus a 48-week gamified digital program focusing on lifestyle modification and remote patient monitoring (RPM). User retention and engagement were high with 84% remaining active at 24 weeks and weekly RPM completion averaging 94%. The primary endpoint was the baseline-adjusted between-group difference in the Second Manifestations of ARTerial disease, version 2 (SMART2) risk score at 6 months. These SMART2 scores did not differ between the intervention and control groups (adjusted mean difference −0.3%; 95% confidence interval −2.4% to 1.9%; P = 0.821). However, the intervention group significantly improved in disease knowledge at 6 and 12 months ( P < 0.001) and medication adherence at 6 months ( P =0.030). Diastolic blood pressure was significantly lower in the intervention group at 12 months (−3.7 mmHg; P = 0.003). In a post hoc exploratory hypothesis-generating subgroup analysis of overweight participants, the intervention significantly reduced SMART2 scores at 12 months compared to controls (−3.7%; P = 0.033). Conclusion While the intervention did not reduce the SMART2 risk score in the overall population, it significantly improved disease knowledge, short-term medication adherence, and diastolic blood pressure. The program was well-accepted and may offer prognostic benefits for overweight patients. Clinical Trial Registration https://clinicaltrials.gov/study/NCT05713565 , NCT05713565.
No takes yet. Share an insight, caveat, or question.
Guðmundsson et al. (2026) conducted an RCT in Coronary artery disease following percutaneous coronary intervention (n=200). SK-121 digital health program vs. Standard of care alone was evaluated on Baseline-adjusted between-group difference in the SMART2 risk score at 6 months (adjusted mean difference -0.3%, 95% CI -2.4 to 1.9, p=0.821). The SK-121 digital health intervention did not significantly reduce the SMART2 risk score at 6 months compared to standard of care alone in patients following percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: